US drugmaker Lilly set to establish regional headquarters in Riyadh

23/03/2021 Argaam

Logo of Eli Lilly and Company

US-based pharmaceuticals major Eli Lilly and Company signed a memorandum of understanding to establish a regional headquarters in King Abdullah Financial District (KAFD).

 

The MoU was signed in the presence of Dimitri Livadas, General Manager of Eli Lilly Saudi Arabia Ltd, and the Saudi Ministry of Investment, represented by Deputy Investor Relations Manager Nasser Almahashir.

 

Established in 1876, Eli Lilly and Company is a leading pharmaceuticals producer, which has a branch in Saudi Arabia.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.